NCT05786170

Brief Summary

  1. 1.How many ERILs occur in caucasian patients with LAA stroke during 7 days on standard treatment?
  2. 2.How many SNILs occur between 7 and 30 days after acute ischemic event on standard treatment?
  3. 3.How many of during acute event diagnosed lesions (ERILs) are (still) detectable after 30 days?
  4. 4.Are there relevant risk faktors for the occurence of ERILs and SNILs (eg Diabetes or Biomarkers)?

Trial Health

15
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Sep 2019

Typical duration for not_applicable

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2019

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 5, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 5, 2021

Completed
1.7 years until next milestone

First Submitted

Initial submission to the registry

March 14, 2023

Completed
13 days until next milestone

First Posted

Study publicly available on registry

March 27, 2023

Completed
Last Updated

March 27, 2023

Status Verified

March 1, 2023

Enrollment Period

1.8 years

First QC Date

March 14, 2023

Last Update Submit

March 14, 2023

Conditions

Stroke, Acute

Outcome Measures

Primary Outcomes (1)

  • 1. How many ERILs occur in caucasian patients with LAA stroke during 7 days on standard treatment?

    DW-MRI to detect lesions

    7 days after acute stroke

Secondary Outcomes (1)

  • 2. How many SNILs occur between 7 and 30 days after acute ischemic event on standard treatment and how many of during acute event diagnosed lesions (ERILs) are (still) detectable after 30 days?

    30 days after acute stroke

Study Arms (1)

magnetic resonance imaging

EXPERIMENTAL

DW-MRI after ischemic stroke

Diagnostic Test: diffusion-weighted magnetic resonance imaging

Interventions

diffusion-weighted magnetic resonance imagingDIAGNOSTIC_TEST

diffusion-weighted magnetic resonance imaging

magnetic resonance imaging

Eligibility Criteria

Age18 Years - 100 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • LAA stroke or TIA
  • ERILs or SNILs detected in initialDW-MRI
  • signed informed consent

You may not qualify if:

  • planned surgical intervention
  • iv Thrombolysis
  • atrial fibrillation
  • contra indications against DW-MRI

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Stroke

Interventions

Diffusion Magnetic Resonance Imaging

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular Diseases

Intervention Hierarchy (Ancestors)

Magnetic Resonance ImagingTomographyDiagnostic ImagingDiagnostic Techniques and ProceduresDiagnosis
0

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD

Study Record Dates

First Submitted

March 14, 2023

First Posted

March 27, 2023

Study Start

September 1, 2019

Primary Completion

July 5, 2021

Study Completion

July 5, 2021

Last Updated

March 27, 2023

Record last verified: 2023-03